Buy, Sell or Hold ABBV Stock? Key Tips Ahead of Q1 Earnings

• click to rate

  Posted by Two Blokes Apr 23 - Filed in Stock - 4 views
  
  Investors will likely focus on the sales performance of AbbVie's blockbuster immunology drugs, Rinvoq and Skyrizi, when it reports Q1 results later this week.